Remove BMI Remove Diabetes Remove Research
article thumbnail

Body mass index impacts the lipid-lowing effects of statins in patients with type 2 diabetes

Frontiers in Cardiovascular Medicine

BackgroundIndividuals diagnosed with type 2 diabetes mellitus (T2DM) commonly exhibit elevated lipid levels and an increased body mass index (BMI). The impact of BMI on the efficacy of statins in reducing lipid levels among diabetic patients remains uncertain.

BMI 52
article thumbnail

Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study

Cardiovascular Diabetology

Patients with low-to-normal body mass index (BMI; < 25.0 kg/m2) were underrepresented in major randomized controlled trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors for type 2 diabetes. The present st.

Diabetes 120
article thumbnail

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study

Cardiovascular Diabetology

BMI variability has been associated with increased cardiovascular disease risk in individuals with type 2 diabetes, however comparison between clinical studies and real-world observational evidence has been la.

BMI 59
article thumbnail

The association between cardiovascular diseases and their subcategories with the severity of chronic obstructive pulmonary disease: a large cross-sectional study based on a Chinese hospital population cohort

Frontiers in Cardiovascular Medicine

Sensitivity analyses reconfirmed the robustness of the associations of CVD and hypertension with COPD severity among patients who excluded bronchiectasis, tuberculosis, lung cancer, pulmonary hypertension, pulmonary heart disease, and diabetes (P<0.05).ConclusionThe

article thumbnail

BMI-residualized data uncovers a cluster of people with type 2 diabetes and increased serum ferritin protected from cardiovascular disease

Cardiovascular Diabetology

Understanding the relationship between serum ferritin levels and cardiovascular outcomes in type 2 diabetes is crucial for improving risk stratification and guiding therapeutic interventions aimed at preventin.

BMI 59
article thumbnail

How Apob & Visceral Fat Increase Your Risk Of Heart Disease.

Dr. Paddy Barrett

Excess weight, as measured by BMI, is typically considered a measure of excess body fat. And the research suggests that it is this excess visceral fat (VAT) that is driving most of the risk. And the research suggests that it is this excess visceral fat (VAT) that is driving most of the risk. Losing 6.5%

article thumbnail

The association between the systemic immune-inflammation index and in-hospital mortality among acute ischemic stroke with atrial fibrillation patients undergoing intravenous thrombolysis

Frontiers in Cardiovascular Medicine

Two sensitivity analyses confirmed the robustness of this association from multiple perspectives (P<0.05).